business
COMPANY BENCHMARKING • UNITED STATES

Quest Diagnostics Inc. - Company Profile

Access all 5,000+ company profiles through the Benchmarking Pro Membership. Unlock interactive competitor comparison tools that show you how Quest Diagnostics Inc. stacks up to the competition and put relevant competitor and industry information at your fingertips.


Quest Diagnostics Inc. - Overview

Brands
AmeriPath, Dermpath Diagnostics, ExamOne, Quanum, Quest Diagnostics
Description
Quest Diagnostics is a public company headquartered in New Jersey with an estimated 49,000 employees. In the US, the company has a notable market share in at least two industries: Healthcare and Social Assistance, Diagnostic & Medical Laboratories and Healthcare and Social Assistance. Their largest market share is in the Diagnostic & Medical Laboratories industry, where they account for an estimated 16.5% of total industry revenue and are considered an All Star because they display stronger market share, profit and revenue growth compared to their peers.
Company Details

Registered Name: Quest Diagnostics Inc.

Company Type: Operating

Exchange: NYSE

Headquarters: 500 Plaza Drive Secaucus NJ 07094

Website: https://www.questdiagnostics.com/

Employees: 49000

Quest Diagnostics Inc. - Operating Industries and Main Competitors

error_outline To view all of Quest Diagnostics Inc.'s operating industries and competitors, see purchase options.

Quest Diagnostics Inc. - Products and Services

  • Healthcare and Social Assistance in the US

    • Of the 4 core revenue-generating products and services in the Healthcare and Social Assistance in the US industry, Quest Diagnostics Inc. offers:
    • Ambulatory healthcare services
    • Hospitals
    • Nursing homes and residential facilities
    • AAAAA AAAAA

  • Diagnostic & Medical Laboratories in the US

    • Of the 6 core revenue-generating products and services in the Diagnostic & Medical Laboratories in the US industry, Quest Diagnostics Inc. offers:
    • Anatomic pathology services
    • Clinical pathology services
    • General pathology services
    • AAAAA AAAAA
error_outline To view Quest Diagnostics Inc.'s full products and services, see purchase options.

Quest Diagnostics Inc. - Analyst Insights

Quest Diagnostics marks two years of COVID-19 testing

In March 2022, Quest Diagnostics marked two years since its first COVID-19 test. Since the company introduced its first COVID-19 tests in March 2020, it has performed about 65.0 million COVID-19 molecular diagnostic tests. While Quest began COVID-19 testing with a single laboratory in California to two dozen labs throughout the US. In the two years of COVID-19 testing, Quest has received 20 emergency use authorizations from the FDA for COVID-19 innovations, developed advanced testing capabilities and collaborated with the CDC and other entities to identify COVID-19 variants.

COVID|ESG


In response to volatile demand in the wake of the first COVID-19 surge, the company undertook a comprehensive cost reduction program, aimed at shoring up labor and supply costs.

Lorem Ipsum text header Report Title

Lorem ipsum dolor sit amet, consectetur adipiscing elit. Maecenas non leo lacinia, consectetur ipsum non, pretium augue. Vestibulum accumsan dignissim massa, eu scelerisque mi malesuada ut. Aliquam scelerisque facilisis nisl ac varius. Nunc luctus nunc vel eros iaculis, vitae tristique ante fringilla. Ut vitae vulputate est, vel lacinia nisi. Curabitur eget nulla vitae mi faucibus imperdiet. Cras sagittis arcu eu diam pharetra iaculis eget sit amet risus. Morbi eget turpis ut diam commodo congue id eu lacus.

Cras sagittis arcu eu diam pharetra iaculis eget sit amet risus. Morbi eget turpis ut diam commodo congue id eu lacus.

error_outline To view all analyst insights on Quest Diagnostics Inc., see purchase options.

Quest Diagnostics Inc. - SWOT Analysis

Strengths and weaknesses take into account internal factors, and are based on Quest Diagnostics Inc.'s performance in comparison to its competitors. Opportunities and Threats focus on external influences, and are based on trends and demand in the Healthcare and Social Assistance in the US, and Diagnostic & Medical Laboratories in the US industries.
Strengths
Days Receivables: x.x%
Purchase a membership to unlock the full SWOT analysis of this company.
lock
Rank: 2 of 3 peers
Lorem Ipsum is simply dummy text of the printing and typesetting industry. Lorem Ipsum has been the industry's standard dummy text ever since the 1500s, when an unknown printer took a galley of type and scrambled it to make a type specimen book.
Annual Turnover: x.x%
Purchase a membership to unlock the full SWOT analysis of this company.
lock
Rank: 2 of 3 peers
Lorem Ipsum is simply dummy text of the printing and typesetting industry. Lorem Ipsum has been the industry's standard dummy text ever since the 1500s, when an unknown printer took a galley of type and scrambled it to make a type specimen book.
Weaknesses
Credit Risk: x.x%
Purchase a membership to unlock the full SWOT analysis of this company.
lock
Rank: 2 of 3 peers
Lorem Ipsum is simply dummy text of the printing and typesetting industry. Lorem Ipsum has been the industry's standard dummy text ever since the 1500s, when an unknown printer took a galley of type and scrambled it to make a type specimen book.
Revenue per Employee: $xx
Purchase a membership to unlock the full SWOT analysis of this company.
lock
Rank: 2 of 3 peers
Lorem Ipsum is simply dummy text of the printing and typesetting industry. Lorem Ipsum has been the industry's standard dummy text ever since the 1500s, when an unknown printer took a galley of type and scrambled it to make a type specimen book.
Opportunities
  • AAAAA
  • AAAAA
  • AAAAA
Threats
  • AAAAA
  • AAAAA
  • AAAAA

error_outline To view Quest Diagnostics Inc.'s full SWOT analysis, see purchase options.

Quest Diagnostics Inc. - Financial Statements & Ratios

pie_chartQuest Diagnostics Inc. Income Statement

BALANCE DATE12/31/202112/31/202012/31/201912/31/201812/31/2017
Revenue10,788.09,437.07,726.07,531.07,402.0
Cost of Revenue00000000000000000000
Cost of Revenue, Non-Cash00000000000000000000
Gross Profit00000000000000000000
AAAAAA AAAAAA00000000000000000000

pie_chartQuest Diagnostics Inc. Balance Sheet

BALANCE DATE12/31/202112/31/202012/31/201912/31/201812/31/2017
Cash and Equivalents872.01,158.01,192.0135.0137.0
Short-Term Investments00000000000000000000
Derivative Assets, Current00000000000000000000
Restricted Cash and Investments00000000000000000000
AAAAAA AAAAAA00000000000000000000

pie_chartQuest Diagnostics Inc. Cash Flow

BALANCE DATE12/31/202112/31/202012/31/201912/31/201812/31/2017
Net Income2,080.01,499.0906.0788.0824.0
Income (Loss) From Discontinued Operations00000000000000000000
Depreciation, Depletion and Amortization00000000000000000000
Amortization of Financing Costs and Discounts00000000000000000000
AAAAAA AAAAAA00000000000000000000

error_outline To view all financial data for Quest Diagnostics Inc., see purchase options.

GET INSTANT ACCESS WITH BENCHMARKING PRO MEMBERSHIP

100% Money Back Guarantee Digicert Trusted

BENCHMARKING PRO

What's Inside
Benchmarking Pro?

A suite of company and industry data that:

Benchmarks companies against industry averages or like-sized segments, as well as close competitors
Identifies real-world strengths, opportunites, weaknesses and threats
Reveals growth opportunities or red flags in a business growth strategy
LEARN MORE

Included in Report

  • Enterprise History & Synopsis
    Enterprise History & Synopsis
  • Enterprise Financial Statements
    Company Financial Statements
  • Financial Ratios
    Industry Market Share Breakdown
  • Industry Averages
    Industry Competitor Matrix
  • Competitive Landscape
    SWOT Analysis
  • Key Enterprise Personnel
    Products and Services
  • Subsidiaries & Ownership Structure
    Key Company Benchmarks

Why purchase access to Benchmarking Pro?

This profile on Quest Diagnostics Inc. includes:

  • Company Overview
  • Company Revenue and Employee Data
  • Company Financial Statements
  • Industry Market Share Breakdown
  • Industry Competitor Matrix
  • SWOT Analysis
  • Products and Services
  • Key Company Benchmarks
  • Interconnected Competitor Profiles and Industry Reports
  • Full Access to Benchmarking Pro

The IBISWorld Benchmarking Pro solution enables you to:

  • Understand an enterprise’s competitive landscape and how they perform within a like-sized industry segment.
  • Benchmark companies against industry averages, segment averages and their competitors.
  • Identify real-world strengths, opportunities, weaknesses and threats for companies.
  • Target growth opportunities or spot red flags in a business growth strategy.
  • Toggle between company profiles and industry reports for a 360 degree view of a company's position.

IBISWorld provides profiles on thousands of leading companies around the world. Our clients rely on our information and data to stay up-to-date on business and industry trends across all sectors of the economy. This company profile, along with the corresponding competitor and industry data provided, includes thoroughly researched, reliable and current information that will help you to make faster, better business decisions.

Trusted by More Than 10,000 Clients Around the World

  • IBISWorld client - VISA
  • IBISWorld client - ADP
  • IBISWorld client - Deloitte
  • IBISWorld client - AMEX
  • IBISWorld client - Bank of Montreal